Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 12, 2019 - Ardelyx announced the FDA approval of Ibsrela (tenapanor), for treatment of irritable bowel syndrome with constipation (IBS-C) in adults.
Download PDF
Return to publications
